The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Circassia Pharmaceuticals plc ("Circassia")


Offer details
Expected size of offer (M): Nil
Expected first date of trading: 04/02/2019
Market: AIM
Location of address at which admission document will be available: N/A - quoted applicant
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Peel Hunt LLP
Nominated Broker (AIM Companies): Peel Hunt LLP, Numis Securities Limited

Company details
Name Role
Dr Francesco Granata Chairman
Steven Charles Andrew Harris Chief Executive Officer and co-founder
Julien Fabrice Cotta Chief Financial Officer
Dr Roderick Peter HafneR Senior Vice President Research and Development
Russell Cummings Non-Executive Director
Sharon Evelyn Curran Independent Non-Executive Director
Joanna Susan Le Couilliard Independent Non-Executive Director

Facts and Figures
Fiscal year end: 31 December
Incorporated in: England and Wales
Website URL: https://www.circassia.com
space
Description of business:
Circassia (the "Company") is a specialty pharmaceutical company focused on respiratory disease. The Company's commercial organisation promotes its innovative asthma management products directly to specialist physicians in a number of key markets, and it markets the chronic obstructive pulmonary disease (COPD) product Tudorza? in the United States in collaboration with AstraZeneca. The Company is e...

Person(s) interested:
Shareholder % of Company pre-admission % of Company post-admission Invesco Asset Management 23.3 23.3 Woodford Investment Management 23.0 23.0 AstraZeneca plc 19.2 19.2 OppenheimerFunds Inc 7.6 7.6 Imperial Innovations Businesses LLP 7.2 7.2 Neptune Investment Management 5.9 5.9 AIT Therapeutics, Inc 3.3 3.3


Circassia Pharmaceuticals plc ("Circassia")

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds